ST2 as a Marker for Risk of Therapy-Resistant Graft-versus-Host Disease and Death

BACKGROUND: No plasma biomarkers are associated with the response of acute graft-versus-host disease (GVHD) to therapy after allogeneic hematopoietic stem-cell transplantation. METHODS: We compared 12 biomarkers in plasma obtained a median of 16 days after therapy initiation from 10 patients with a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Vander Lugt, Mark T., Braun, Thomas M., Hanash, Samir, Ritz, Jerome, Ho, Vincent T., Antin, Joseph H., Zhang, Qing, Wong, Chee-Hong, Wang, Hong, Chin, Alice, Gomez, Aurélie, Harris, Andrew C., Levine, John E., Choi, Sung W., Couriel, Daniel, Reddy, Pavan, Ferrara, James L. M., Paczesny, Sophie
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3943357/
https://ncbi.nlm.nih.gov/pubmed/23924003
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa1213299
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados